• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nasal absorption of hydroxocobalamin in healthy elderly adults.健康老年人中羟钴胺素的鼻腔吸收情况。
Br J Clin Pharmacol. 1998 Jan;45(1):83-6. doi: 10.1046/j.1365-2125.1998.00642.x.
2
Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status.口服氰钴胺或羟钴胺后,健康低钴胺素和正常钴胺素状态人群的循环全钴胺素增加。
Eur J Nutr. 2018 Dec;57(8):2847-2855. doi: 10.1007/s00394-017-1553-5. Epub 2017 Oct 16.
3
Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients.鼻内给予羟钴胺使维生素B12缺乏患者血浆维生素B12浓度正常化。
Gastroenterology. 1997 Aug;113(2):430-3. doi: 10.1053/gast.1997.v113.pm9247460.
4
Hydroxocobalamin analysis and pharmacokinetics.羟钴胺素分析与药代动力学。
J Toxicol Clin Toxicol. 1997;35(4):409-15; author reply 417. doi: 10.3109/15563659709043375.
5
Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.比较通过水性鼻喷雾剂或氢氟烷烃鼻气雾剂给予与口服给予的昔萘酸氯替泼诺和去异丁酰基昔萘酸氯替泼诺的药代动力学:一项在健康志愿者中进行的开放性、单剂量、三周期交叉研究。
Clin Ther. 2009 Dec;31(12):2988-99. doi: 10.1016/j.clinthera.2009.12.002.
6
Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.大鼠和人类经鼻腔及静脉给药后,羟钴胺向脑脊液中的摄取情况。
J Drug Target. 2003 Jul;11(6):325-31. doi: 10.1080/10611860310001640075.
7
Biosynthesis of 32P-labelled hydroxocobalamin and a study of its behaviour in rats.32P 标记的羟钴胺素的生物合成及其在大鼠体内行为的研究。
Scand J Clin Lab Invest. 2004;64(5):451-6. doi: 10.1080/00365510410006685.
8
Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.重组人促红细胞生成素三种不同静脉制剂在健康韩国成年男性志愿者中的药代动力学、耐受性及生物等效性比较:一项开放标签、随机序列、三治疗组、三交叉研究
Clin Ther. 2009 May;31(5):1046-53. doi: 10.1016/j.clinthera.2009.05.013.
9
Effect of 8-week oral supplementation with 3-µg cyano-B12 or hydroxo-B12 in a vitamin B12-deficient population.维生素 B12 缺乏人群口服 3μg 氰钴胺或羟钴胺 8 周的效果。
Eur J Nutr. 2019 Feb;58(1):261-270. doi: 10.1007/s00394-017-1590-0. Epub 2017 Dec 5.
10
Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.健康志愿者单次高剂量通过Aerolizer吸入福莫特罗干粉剂(奥克斯都保)后的药代动力学及耐受性研究
Eur J Clin Pharmacol. 1999 Apr;55(2):131-8. doi: 10.1007/s002280050607.

引用本文的文献

1
Practical supplements for prevention and management of migraine attacks: a narrative review.偏头痛发作预防与管理的实用补充剂:一项叙述性综述
Front Nutr. 2024 Oct 30;11:1433390. doi: 10.3389/fnut.2024.1433390. eCollection 2024.
2
Vitamin B in Foods, Food Supplements, and Medicines-A Review of Its Role and Properties with a Focus on Its Stability.食品、食品补充剂和药物中的维生素 B:作用和性质综述,重点关注其稳定性。
Molecules. 2022 Dec 28;28(1):240. doi: 10.3390/molecules28010240.
3
Current Nanocarrier Strategies Improve Vitamin B12 Pharmacokinetics, Ameliorate Patients' Lives, and Reduce Costs.当前的纳米载体策略改善了维生素B12的药代动力学,改善了患者生活,并降低了成本。
Nanomaterials (Basel). 2021 Mar 16;11(3):743. doi: 10.3390/nano11030743.
4
Systematic Review and Pragmatic Clinical Approach to Oral and Nasal Vitamin B12 (Cobalamin) Treatment in Patients with Vitamin B12 Deficiency Related to Gastrointestinal Disorders.维生素B12缺乏相关胃肠道疾病患者口服和鼻用维生素B12(钴胺素)治疗的系统评价与实用临床方法
J Clin Med. 2018 Sep 26;7(10):304. doi: 10.3390/jcm7100304.
5
Effect of administration route on the pharmacokinetics of cobalamin in elderly patients: a randomized controlled trial.给药途径对老年患者钴胺素药代动力学的影响:一项随机对照试验。
Curr Ther Res Clin Exp. 2014 Mar 20;76:21-5. doi: 10.1016/j.curtheres.2014.01.001. eCollection 2014 Dec.
6
Cobalamin deficiency in elderly patients: a personal view.老年患者的钴胺素缺乏:个人观点。
Curr Gerontol Geriatr Res. 2008;2008:848267. doi: 10.1155/2008/848267. Epub 2008 May 26.
7
Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients.老年患者口服氰钴胺(维生素B12)治疗的最新进展
Drugs Aging. 2008;25(11):927-32. doi: 10.2165/0002512-200825110-00003.
8
Vitamin B12 (cobalamin) deficiency in elderly patients.老年患者维生素B12(钴胺素)缺乏症
CMAJ. 2004 Aug 3;171(3):251-9. doi: 10.1503/cmaj.1031155.

本文引用的文献

1
Activity of Vitamin B12 in Addisonian Pernicious Anemia.维生素B12在阿狄森氏恶性贫血中的活性
Science. 1948 Apr 16;107(2781):398. doi: 10.1126/science.107.2781.398.
2
STUDIES ON VITAMIN B12 RETENTION. COMPARISON OF RETENTION FOLLOWING INTRAMUSCULAR INJECTION OF CYANOCOBALAMIN AND HYDROXOCOBALAMIN.维生素B12潴留的研究。肌肉注射氰钴胺和羟钴胺后潴留情况的比较。
Scand J Haematol. 1964;1:5-15. doi: 10.1111/j.1600-0609.1964.tb00001.x.
3
Oral vitamin B12 without intrinsic factor in the treatment of pernicious anemia.口服无内因子维生素B12治疗恶性贫血。
Ann Intern Med. 1963 May;58:810-7. doi: 10.7326/0003-4819-58-5-810.
4
Studies on hydroxocobalamin. I. Excretion and retention of massive doses in control subjects.羟钴胺素的研究。I. 对照受试者中大量剂量的排泄与潴留情况。
J Lab Clin Med. 1961 Apr;57:553-61.
5
Treatment of pernicious anemia by oral administration of vitamin B12 without added intrinsic factor.口服不含内因子的维生素B12治疗恶性贫血。
N Engl J Med. 1959 Feb 19;260(8):361-7. doi: 10.1056/NEJM195902192600803.
6
The treatment of pernicious anaemia by insufflation of vitamin B12.通过维生素B12吹入法治疗恶性贫血。
Lancet. 1954 Feb 13;266(6807):341-3. doi: 10.1016/s0140-6736(54)91089-2.
7
Nasal instillation and inhalation of crystalline vitamin B12 in pernicious anemia.恶性贫血中晶体维生素B12的滴鼻和吸入疗法
AMA Arch Intern Med. 1954 Feb;93(2):219-30. doi: 10.1001/archinte.1954.00240260055005.
8
Crystalline B12 inhalation therapy in pernicious anemia.结晶维生素B12吸入疗法治疗恶性贫血
Am J Med Sci. 1953 Feb;225(2):113-9. doi: 10.1097/00000441-195302000-00001.
9
Cyanocobalamin--a case for withdrawal.氰钴胺素——停用的一个案例
J R Soc Med. 1993 May;86(5):309.
10
Prevalence of cobalamin deficiency in the Framingham elderly population.弗雷明汉老年人群中钴胺素缺乏症的患病率。
Am J Clin Nutr. 1994 Jul;60(1):2-11. doi: 10.1093/ajcn/60.1.2.

健康老年人中羟钴胺素的鼻腔吸收情况。

Nasal absorption of hydroxocobalamin in healthy elderly adults.

作者信息

van Asselt D Z, Merkus F W, Russel F G, Hoefnagels W H

机构信息

Department of Geriatric Medicine, University Hospital Nijmegen, The Netherlands.

出版信息

Br J Clin Pharmacol. 1998 Jan;45(1):83-6. doi: 10.1046/j.1365-2125.1998.00642.x.

DOI:10.1046/j.1365-2125.1998.00642.x
PMID:9489599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1873990/
Abstract

AIMS

To investigate the nasal absorption of hydroxocobalamin in 10 healthy elderly adults.

METHODS

In a cross-over study, blood samples were collected before administration of the drug and after 10, 20, 30, 40, 60, 120, 180 and 240 min. The plasma cobalamin concentration was determined by competitive radioisotope binding technique.

RESULTS

The maximal plasma cobalamin concentration (Cmax) after nasal administration of 750 microg hydroxocobalamin was 1900 +/- 900 pmol l(-1) (mean +/- s.d.). The maximal plasma cobalamin concentration was reached in 35 +/- 13 min (t[max]). The Cmax after nasal administration of 1500 microg hydroxocobalamin was 3500 +/- 2500 pmol l(-1) with a t(max) of 28 +/- 16 min. Both the AUC(0,240 min) and AUC(0,00) increased significantly with an increase of the dose from 750 microg to 1500 microg (P = 0.037 and P = 0.028, respectively). The nasal spray was well tolerated. No signs of irritation or local sensitivity were noted.

CONCLUSIONS

The nasal absorption of hydroxocobalamin in healthy elderly adults is rapid, high and well tolerated.

摘要

目的

研究10名健康老年成年人中羟钴胺素的鼻腔吸收情况。

方法

在一项交叉研究中,于给药前以及给药后10、20、30、40、60、120、180和240分钟采集血样。采用竞争性放射性同位素结合技术测定血浆钴胺素浓度。

结果

鼻腔给予750微克羟钴胺素后,血浆钴胺素最大浓度(Cmax)为1900±900皮摩尔/升(均值±标准差)。在35±13分钟(t[max])时达到血浆钴胺素最大浓度。鼻腔给予1500微克羟钴胺素后的Cmax为3500±2500皮摩尔/升,t(max)为28±16分钟。随着剂量从750微克增加到1500微克,AUC(0,240分钟)和AUC(0,∞)均显著增加(分别为P = 0.037和P = 0.028)。鼻腔喷雾剂耐受性良好。未观察到刺激或局部敏感迹象。

结论

健康老年成年人中羟钴胺素的鼻腔吸收迅速、高效且耐受性良好。